Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria
Sakaguchi, Tadashi, Ito, Kentaro, Furuhashi, Kazuki, Nakamura, Yuki, Suzuki, Yuta, Nishii, Yoichi, Taguchi, Osamu, Hataji, OsamuLanguage:
english
Journal:
Respiratory Investigation
DOI:
10.1016/j.resinv.2019.03.011
Date:
May, 2019
File:
PDF, 535 KB
english, 2019